Skip to main content

Table 6 Intermediate precision study

From: Impurity profiling method development and validation of metformin hydrochloride and teneligliptin hydrobromide hydrate in their combination tablet dosage form by using RP-HPLC with UV/PDA detector

S. no API/impurity Spl.1 Spl.2 Spl.3 Spl.4 Spl.5 Spl.6 %RSD
1 CYN 0.013 0.015 0.014 0.015 0.014 0.014 5.3
2 Melamine 0.004 0.004 0.003 0.004 0.004 0.004 10.6
3 TNG Impurity A ND ND ND ND ND ND ND
4 TNG Impurity B ND ND ND ND ND ND ND
5 Single Mix. Imp 0.089 0.086 0.084 0.078 0.082 0.091 5.6
6 Total impurities 0.316 0.308 0.296 0.298 0.325 0.308 3.53